Apollo Endosurgery Announces CE Mark Approval for the ORBERA365™ Managed Weight Loss System, Expanding the Indwell Period from 6 Months to 12 Months with the Gastric Balloon Category Leader

Apollo Endosurgery, Inc. (“Apollo”), a global leader in less invasive medical devices for bariatric and gastrointestinal procedures, today announced CE Mark approval for the ORBERA365 Managed Weight Loss System.